help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 27, 2007
Endocrinology, doi:10.1210/en.2007-1315
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/4/1802    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zappala, G.
Right arrow Articles by Bhattacharyya, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zappala, G.
Right arrow Articles by Bhattacharyya, N.

Submitted on September 26, 2007
Accepted on December 17, 2007

Induction of Apoptosis in Human Prostate Cancer Cells by IGF Binding Protein-3 Does not Require Binding to Retinoid X Receptor-{alpha}

Giovanna Zappala, Cem Elbi, Joanna Edwards, Julie Gorenstein, Matthew M. Rechler*, and Nisan Bhattacharyya

Diabetes Branch (G.Z., J.E., M.M.R., N.B.), NIDDK, National Institutes of Health, Bethesda, Maryland 20892 and Department of Cancer Pathways (C.E., J.G.), Merck Research Laboratories, Boston, MA 02115

* To whom correspondence should be addressed. E-mail: mrechler{at}helix.nih.gov.

IGF-binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells directly without sequestering IGF-I and IGF-II. The molecular mechanisms responsible for the IGF-independent actions of IGFBP-3 remain unclear. IGFBP-3, a secreted protein, can be internalized and translocate to the nucleus. It binds to the nuclear retinoid receptor RXR-{alpha}. Binding to RXR-{alpha} has been proposed to be required for IGFBP-3 to induce apoptosis. The present study tests this hypothesis in PC-3 human prostate cancer cells. PC-3 cells express RXR-{alpha}, and apoptosis is induced by incubation with RXR-specific ligand. A COOH-terminal region in IGFBP-3 (residues 215–232) contains a nuclear localization signal (NLS) and binding domains for RXR-{alpha} and heparin (HBD). Different combinations of the 11 amino acids in this region that differ from IGFBP-1, a related IGFBP which does not localize to the nucleus or bind RXR-{alpha}, were mutated to the IGFBP-1 sequence. By confocal imaging, mutation of residues 228-KGRKR-232 in nonsecreted IGFBP-3 diminished its nuclear localization. IGFBP-3 binding to GST-RXR-{alpha} only was lost when all 11 sites were mutated (HBD-11m-IGFBP-3). Expressed nuclear RXR-{alpha} did not transport cytoplasmic IGFBP-3 NLS mutants that can bind RXR-{alpha} to the nucleus even after treatment with RXR-ligand. Expressed HBD-11m-IGFBP-3 still induced apoptosis in PC-3 cells in an IGF-independent manner as determined by flow cytometric analysis of Annexin V staining. We conclude that in PC-3 cells RXR-{alpha} is not required for the nuclear translocation of IGFBP-3, and that IGFBP-3 can induce apoptosis in human prostate cancer cells without binding RXR-{alpha}.


Key words: IGFBP-3 • RXR-{alpha} • Apoptosis • Human Prostate Cancer Cells







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society